Replies to post #38135 on Medizone Intl. (fka MZEIQ)

[goforthebet]

how can we find something he wrote in an email to you??

[Eli's Gone]

Not sure what you're looking for...these type blurbs were part of the "Our Strategy" section of the website up until the "Our Strategy" section disappeared sometime in 2014:

Our Strategy:

Partnership with Multinational Corporation

Medizone International expects to partner with a large corporation embedded in the hospital sector for increased:

Manufacturing Capacity
National and international sales
Increased service capabilities

Partnership / Joint Ventures

Medizone International expects to partner with a large corporation embedded in the hospital sector for increased:

Manufacturing Capacity
National and international sales
Increased service capabilities

[goforthebet]

maybe you refere to this in the CC??

Ed Marshall
Thank you, Tommy. Today we are going to try and answer a number of questions that have been submitted by shareholders for this call. At the end of the call, I will make some additional comments with the intention of clarifying where the company believes it is overall relative to achieving production, sales and our future strategies moving forward. Jill, would you please proceed with the first question.

http://medizoneint.com/wp-content/uploads/2011/06/June-8-Conference-Call.pdf

OR HERE

Medizone International Inc. Appoints David Esposito to Its Board

Finally, Medizone International Inc. (OTCQB:MZEI - News) share volume soared Apr. 22, with 1,110,844 changing hands, more than twice its average three-month volume of 549,905 shares.

The Sausalito-based company designs, manufactures and sells a patented system using ozone in the disinfection of surgical and other medical treatment facilities.

Its recent surge in stock volume could be triggered in part by the company’s recent announcement of the addition of David Esposito to its board of directors

According to Medizone, it made the move in anticipation of full U.S. regulatory approval of the company's AsepticSure® hospital disinfection system.

"As Medizone International continues to move forward with our growth strategy, it is important that we continue to attract talented commercial leaders to help the organization reach its potential in establishing the AsepticSure system as the new gold standard for disinfection across a wide range of commercial applications," said CEO of Medizone International Edwin Marshall. "As we prepare for the global commercialization of the AsepticSure system, we are pleased to announce that David Esposito has joined our Board of Directors to help support our commercial strategy and business development initiatives,” he added.

Stellar Qualifications

Esposito has tremendous commercial experience as a senior executive in both the pharmaceutical and medical diagnostic markets.

Over a 15-year career with Merck & Co., Esposito played key roles in sales, marketing, and commercial strategy. Esposito, as the former President and General Manager of Phadia US Inc., a leading specialty diagnostics company, helped drive significant growth in the US market and was a key member of the Phadia Leadership Team that successfully sold the business to Thermo Fisher Scientific for $3.5 Billion USD in 2011.

Post the acquisition, Esposito led the US Commercial Operations for a division of Thermo Fisher Scientific. Prior to his commercial success in the healthcare marketplace, David graduated from the United States Military Academy at West Point with a BS in Civil Engineering. As an Infantry Platoon Leader with the 101st Airborne Division, Esposito was awarded a Bronze Star during the Persian Gulf War. David also holds a Master of Business Administration from Syracuse University.

On Apr. 22, MZEI’s share price closed at 29 cents, up 3 cents from the previous day’s close of 26 cents a share.

Sign up today for timely and hot stock alerts here, or by cutting and pasting the following link in your Web browser:

https://ca.finance.yahoo.com/news/terra-tech-corp-releases-revenue-guidance-7-million-135500482.html